Content DefaultAgenda
Hacke W. Transcranial laser therapy in acute stroke treatment: results of Neurothera effectiveness and safety trial 3, a phase III clinical end point device trial. Stroke. 2014;45(12):E309-E. Google Scholar Salehpour F, Sadigh-Eteghad S, Mahmoudi J, Kamari F, Cassano P, Hamblin MR. ...
The final goal would be the realization of an electro optical modulator. Finally, we also studied multimode laser emission as a potential probe of photopolymerizable media.doi:10.1016/j.oftal.2010.11.018de la Paz, M.FBibliogr
Kinetic measurements have shown that these internal photocycloadditions are of the type [4π a + 2π a ], which is forbidden by Woodward-Hoffmann rules. In all of the three cases studied by us, orbital factors seem anyway to play a major role compared to steric constraints (an endo-endo...
doi:10.1002/bscb.19620711110First page of articleNicolet, MarcelCNRE 3, Avenue Circulaire, BruxellesJohn Wiley & Sons, Ltd.Bulletin des Sociétés Chimiques Belges
Extracorporeal photopheresis (ECP) has objective activity in the treatment of both acute and chronic corticosteroid-refractory GvHD patients, has an excellent safety profile and is internationally well-established. ECP has been recommended by a significant number of renowned scientific organizations as an...
BackgroundExtracorporeal photopheresis (ECP) is an effective treatment for both acute and chronic graft-versus-host disease (GVHD) in children and adults. Despite the large use of this treatment, a large heterogeneity in current application of ECP has been reported so far and recent evidence ...
Extracorporeal photopheresis (ECP) with an immunomodulatory effect, is favored in the treatment of both acute and chronic steroid refractory GVHD as it does not increase the risk of relapses or infections. Having a low profile of side effects, ECP is also generally well-tolerated by patients. ...
Study of the photodegradation and the “colorability” of non-azaheterocyclic spiropyrans by repeated flashes showed the influence of different effects involving the heteroatom, the substituent and the concentration. Substituents in 3′, 6′ and 8′ positions of the benzopyran part are very important...
Chronic GVHD came earlier in the group that started photochemotherapy after 1 week of acute GHVD, but chronic GVHD did not increase the GVL. Conclusion: The timing of photochemotherapy after cutaneous acute GVHD may direct the GVL and predict long-term leukemia-free survival. (C) 2017 S. ...